|
⚲
|
| Keyboard |
| Schranz Jennifer
✚
|
|
|---|---|
| CIK # | 0001735382 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001735382] | |
| 4 | [0001735382] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nabriva Therapeutics AG | |
| Schranz Jennifer |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2021-02-28 | Tax withheld | 33 | $2.39 | 79 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2021-01-31 | Tax withheld | 36 | $2.62 | 94 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2021-01-29 | Grant | 22,500 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-12-31 | Tax withheld | 30 | $2.42 | 73 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-11-30 | Tax withheld | 301 | $0.43 | 129 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-10-31 | Tax withheld | 301 | $0.50 | 150 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-09-30 | Tax withheld | 301 | $0.53 | 160 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-08-31 | Tax withheld | 301 | $0.62 | 187 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-07-31 | Tax withheld | 301 | $0.76 | 229 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-06-30 | Tax withheld | 301 | $0.67 | 202 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-05-31 | Tax withheld | 301 | $1.14 | 343 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-04-30 | Tax withheld | 301 | $0.55 | 166 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-03-31 | Tax withheld | 301 | $0.58 | 175 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-02-28 | Tax withheld | 301 | $1.35 | 406 |
|
Nabriva Therapeutics AG NBRV
Stock Options · derivative
|
2020-02-06 | Grant | 210,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-02-06 | Grant | 105,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2020-01-31 | Tax withheld | 4,295 | $1.35 | 5,798 |
|
Nabriva Therapeutics AG NBRV
Restricted Stock Units · derivative
|
2019-01-31 | Grant | 52,500 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Stock Options · derivative
|
2019-01-31 | Grant | 235,000 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2018-06-22 | Buy | 5,500 | $3.73 | 20,515 |
| showing 20 of 21 most recent transactions | |||||